Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Regeneron Pharmaceuticals Inc    REGN   US75886F1075

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/10/2014 09/11/2014 09/12/2014 09/15/2014 09/16/2014 Date
354.32(c) 350.34(c) 346.06(c) 346.03(c) 355.6075 Last
663 645 381 100 573 760 539 439 597 847 Volume
+2.29% -1.12% -1.22% -0.01% +2.77% Change
More quotes
Company
Regeneron Pharmaceuticals, Inc. operates as a biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer and a rare inflammatory condition and... 
Sector
Pharmaceuticals
Calendar
11/04Earnings Release
Surperformance© rating of Regeneron Pharmaceuticals
Trading Rating : Investor Rating :
More about the company
Chart REGENERON PHARMACEUTICALS
Duration : Period :
Regeneron Pharmaceuticals  Technical Analysis Chart | REGN | US75886F1075 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 2 809 M
EBIT 2014 1 063 M
Net income 2014 423 M
Finance 2014 1 141 M
Yield 2014 -
Sales 2015 3 504 M
EBIT 2015 1 530 M
Net income 2015 775 M
Finance 2015 2 362 M
Yield 2015 -
PER 2014 93,79
PER 2015 52,74
EV / Sales 2014 12,0x
EV / Sales 2015 9,31x
Capitalization 34 975 M
More Financials
Latest news on REGENERON PHARMACEUTICALS
7h ago REGENERON PHARMACEUTICALS : EYLEA® (aflibercept) Injection Receives FDA Breakthr..
6d ago REGENERON PHARMACEUTICALS : Announces Submission of Application for EYLEA® aflib..
6d ago REGENERON PHARMACEUTICALS : Patent Application Titled "Genetically Modified Majo..
09/09 REGENERON PHARMACEUTICALS : Biotech Stocks Under Review -- Keryx Biopharma, Sang..
09/08 NASDAQ 100 MOVERS : Regn, yhoo
09/07 REGENERON PHARMACEUTICALS : and Sanofi Updates on Positive Results from 4 Aliroc..
09/04 REGENERON PHARMACEUTICALS : Patent Issued for Conditioned Culture Media
09/04 NASDAQ 100 MOVERS : Spls, fast
09/04 REGENERON PHARMACEUTICALS : Announces Submission of Application for EYLEA® (afli..
09/04 REGENERON PHARMACEUTICALS : and Sanofi Reports Positive Results from 4 Alirocuma..
09/02DJMARKET SNAPSHOT : S&P 500 Falls Back Under 2,000 As Stocks Slip
09/02 S&P 500 MOVERS : Wynn, spls
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
Regeneron Pharmaceuticals  : Income Statement Evolution
More Financials
EPS Revisions
Regeneron Pharmaceuticals  : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF